This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Dr Alani also directs a clinical program at Boston Medical Center focused on patients with melanoma and other high-risk skin cancers and has been recognized as a 2024 Boston Magazine and Castle Connolly Top Doctor. Dr Alani received her M.D. degree with Honors and Distinction in Research from the University of Michigan.
He has a post-doctorate in virology, viral pathogenesis, viral vector development, and vaccines evaluation from Harvard MedicalSchool, and a PhD in virology/molecularbiology. Anis also serves on the scientific and editorial advisory board of Genetic Engineering News at Mary Ann Liebert, Inc.
Patients with possible undiagnosed infections kept him up at night as he ran through their medical histories, occupations, and personal life details in his mind, searching for clues to the identity of the microscopic invaders. A combined MD/PhD program offered both opportunities.
In 1926, one of Cohn’s academic colleagues at Harvard MedicalSchool discovered that patients suffering from pernicious anemia, a form of vitamin B12 deficiency, could be cured by eating liver. In 1929 and 1930, two medicaldoctors working with Cohn — George R. At the time, the U.S. Minot and William P.
We organize all of the trending information in your field so you don't have to. Join 15,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content